Deanol pidolate
Deanol pidolate (V0191; DMAE pidolate) is an orally active pro-cholinergic agent that improves cognitive symptoms by increasing the release of acetylcholine (Ach) and avoids the typical side effects of cholinesterase inhibitors. Deanol pidolate can alleviate the harmful effects of scopolamine on long-term memory and restore to baseline levels more quickly. Deanol pidolate can be used in research on Alzheimer's disease[1].
Product Specifications
CAS Number
23513-72-6
Product Name Alternative
V0191; DMAE pidolate; DMAE PCA
UNSPSC
12352005
Target
MAChR
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(O)[C@H](CC1)NC1=O.CN(CCO)C
Molecular Formula
C9H18N2O4
Molecular Weight
218.25
References & Citations
[1]Dubois B, et al. Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease. J Alzheimers Dis. 2012;29 (3) :527-35.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402130-500 1x 500 µL
Cytokeratin 3 (KRT3) (Corneal Epithelial Marker) (KRT3/2130), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB0806-500 1x 500 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), 0.2mg/mL
Sign In for Pricing
View Details 
BNC740940-500 1x 500 µL
Glucose Regulated Protein 94 (GRP94) (9G10.F8.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401221-100 1x 100 µL
Cytokeratin 8/18 (B22.1 + B23.1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details